LoValTech

Val-de-roulans, France

LoValTech is a mucosal platform that will revolutionize vaccination.

$5.3M raised

Jul 2023

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has LoValTech raised?

LoValTech has raised $5.3M in total funding. The most recent round was Grant. The last funding was announced in July 2023.

Who are LoValTech's investors?

LoValTech's investors include France 2030.

Where is LoValTech headquartered?

LoValTech is headquartered in Val-de-roulans, France.

What does LoValTech do?

LoValTech is a mucosal platform that will revolutionize vaccination.

What stage is LoValTech at?

LoValTech is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 25, 2023.

MLA

"LoValTech — Funding & Investors." VCBacked, July 25, 2023, https://www.vcbacked.co/company/lovaltech. Accessed July 2, 2026.

APA

VCBacked. (2023). LoValTech — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/lovaltech

Wikipedia (cite web)

{{cite web |title=LoValTech — Funding & Investors |url=https://www.vcbacked.co/company/lovaltech |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 25, 2023.